Current Edition

Non-clinical evaluations for anti-cancer
Volume 2 Issue 1

Non-clinical Evaluations for Anti-cancer Drugs with ICH S9 Guideline Q&A – What the Industry Needs to Know

The ICH S9 Guideline Q&A document – published in June 2018 – is designed to clarify some of the most common challenges experienced across the …

Continue Reading →
Raising organisational fluency
Volume 2 Issue 1

Raising Organisational Fluency in Real-world Evidence

The planet is currently experiencing global healthcare crises that affect huge populations. From diabetes to Alzheimer’s to mental health conditions, we still lack real-world data …

Continue Reading →
Applying standardised NMR spectroscopy
Volume 2 Issue 1

Applying Standardised NMR Spectroscopy to Research Human Diseases

In this article Professor Matthias Nauck of Universitätsmedizin Greifswald and Roland Leiminger of Bruker BioSpin examine the importance of Biobanks and how they are continuously …

Continue Reading →
Alzheimer's disease_the way forward
Volume 2 Issue 1

Alzheimer’s Disease: The Way Forward

Emily Burke at Biotech Primer examines Alzheimer’s disease (AD) and how it ranks as one of the toughest nuts to crack within drug discovery and …

Continue Reading →
Artificial intelligence expands the destiny
Volume 2 Issue 1

Artificial Intelligence Expands the Destiny of DNA Analysis

DNA is the code that has defined humanity for millennia. Until more recently, DNA has determined destiny. There was no escaping its design and code …

Continue Reading →
Diagnosis still poses the biggest challenge
Volume 2 Issue 1

Diagnosis Still Poses the Biggest Challenge in the AIDS Battle

Significant progress has been made in the AIDS response since 1988, however ensuring a swift and accurate diagnosis accessible to everyone is still a significant …

Continue Reading →
Clinical and investigator-initiated trials's effect
Volume 2 Issue 1

Clinical and Investigator-initiated Trials’ Effect on MSL Responsibilities

Among the many responsibilities assigned to medical science liaisons (MSLs) is facilitating company collaboration with thought leaders on clinical trial work. According to MSL teams …

Continue Reading →
Antibodies exploration thanks to label-free
Volume 2 Issue 1

Antibodies Exploration Thanks to Label-free Surface Plasmon Resonance Imaging Technology

Surface plasmon resonance imaging allows the study of molecules binding in label-free and real-time conditions. The power of the technique comes from its singularities, which …

Continue Reading →
The effect of insulin on cell growth
Volume 2 Issue 1

The Effect of Insulin on Cell Growth and Virus Production

This article by Aziza Manceur from National Research Council Canada describes a project whose goal was to test insulin as a booster for cell growth …

Continue Reading →
The drug delivery innovation league table
Volume 2 Issue 1

The Drug Delivery Innovation League Table – Germany and France Lead the Way in Europe

The last two years have been some of the most remarkable years in pharmaceutical history. There were 46 FDA approvals in 2017, and this year …

Continue Reading →
LIMS and ISO_IEC 17025_an opportunity
Volume 2 Issue 1

LIMS and ISO/IEC 17025 – An Opportunity, Not a Burden

Laboratory information management systems (LIMS) have wide-ranging usage within pharmaceutical organisations, wherever samples need to be taken, tested and the results evaluated, including QA/QC, stability …

Continue Reading →
Understanding critical quality attributes
Volume 2 Issue 1

Understanding Critical Quality Attributes

With the increasing prominence of biopharmaceutical products in the modern therapeutic landscape, it has become vitally important to ensure the manufacture of these products is …

Continue Reading →